These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4892242)

  • 1. Respository drugs. IV. 4',4'''-Sulfonylbisacetanilide (Acedapsone, DADDS) and related sulfanilylanilides with prolonged antimalarial and antileprotic action.
    Elslager EF; Gavrilis ZB; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):357-63. PubMed ID: 4892242
    [No Abstract]   [Full Text] [Related]  

  • 2. Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents.
    Elslager EF; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):363-7. PubMed ID: 4977944
    [No Abstract]   [Full Text] [Related]  

  • 3. Repository drugs. VI. 4'-[N-(Aralkylidene-, -Benzylidene-, and -naphthylidene)sulfanilyl]anilides, 4'-[N-[(Dimethylamino)methylene]sulfanilyl]anilides, and related sulfanilylanilides with prolonged antimalarial and antileprotic action.
    Worth DF; Elslager EF; Phillips AA
    J Med Chem; 1969 Jul; 12(4):591-6. PubMed ID: 4978365
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of leprosy.
    Shepard CC
    Annu Rev Pharmacol; 1969; 9():37-50. PubMed ID: 4892433
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones.
    Colwell WT; Chan G; Brown VH; DeGraw JI; Peters JH; Morrison NE
    J Med Chem; 1974 Jan; 17(1):142-4. PubMed ID: 4585972
    [No Abstract]   [Full Text] [Related]  

  • 6. A new repository antimalarial agent, CI-564, used in a field trial in New Guinea.
    Rieckmann KH
    Trans R Soc Trop Med Hyg; 1967; 61(2):189-98. PubMed ID: 6047753
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of spectrophotofluorometric procedures to some problems in Mycobacterium leprae infections in mice and man treated with dapsone (DDS), diacetyl-DDS (DADDS), and di-formyl-DDS (DFD).
    Ozawa T; Shepard CC; Karat AB
    Am J Trop Med Hyg; 1971 Mar; 20(2):274-81. PubMed ID: 4928595
    [No Abstract]   [Full Text] [Related]  

  • 8. Repository drugs. VII. N-Allylidene-4,4'-sulfonyldianiline and N-(benzylidene- and -1-naphthylmethylene)-N'-methylene-4,4'-sulfonyldianiline polymers with prolonged antimalarial and antileprotic action.
    Elslager EF; Capps DB; Worth DF
    J Med Chem; 1969 Jul; 12(4):597-9. PubMed ID: 5793147
    [No Abstract]   [Full Text] [Related]  

  • 9. Repository antimalarial drugs: N,N'-diacetyl-4,4'-diaminodiphenylsulphone and related 4-acylaminodiphenylsulphones.
    Elslager EF; Worth DF
    Nature; 1965 May; 206(984):630-1. PubMed ID: 4953605
    [No Abstract]   [Full Text] [Related]  

  • 10. Acedapsone treatment of leprosy patients: response versus drug disposition.
    Peters JH; Murray JF; Gordon GR; Levy L; Russell DA; Scott GC; Vincin DR; Shepard CC
    Am J Trop Med Hyg; 1977 Jan; 26(1):127-36. PubMed ID: 842774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary studies on the anti-malarial activity of SDDS (2-sulfamoyl-4, 4'-diaminodiphenylsulfone) against Plasmodium berghei and Plasmodium gallinaceum.
    Ishii A; Sasa M; Chinzei H; Oshima S; Tanaka H
    Jpn J Exp Med; 1967 Aug; 37(4):301-21. PubMed ID: 5301401
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug resistance in Plasmodium and the development of antimalarial agents].
    Chu SM
    Zhonghua Yi Xue Za Zhi; 1974; (8):504-7. PubMed ID: 4212621
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
    Dhople AM
    Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 15. Repository drugs. 8. Ester and amide congeners of amodiaquine, hydroxychloroquine, oxychloroquine, primaquine, quinacrine, and related substances as potential long-acting antimalarial agents.
    Elslager EF; Tendick FH; Werbel LM
    J Med Chem; 1969 Jul; 12(4):600-7. PubMed ID: 5793148
    [No Abstract]   [Full Text] [Related]  

  • 16. The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1972 Jul; 21(4):440-5. PubMed ID: 4559065
    [No Abstract]   [Full Text] [Related]  

  • 17. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 18. Further experience with the kinetic method for the study of drugs against Mycobacterium leprae in mice. Activities of DDS, DFD, ethionamide, capreomycin and PAM 1392.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1969; 37(4):389-97. PubMed ID: 4918202
    [No Abstract]   [Full Text] [Related]  

  • 19. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique antinucleic acid approach to the mass screening of antimalarial drugs.
    Van Dyke K; Szustkiewicz C; Cenedella R; Saxe LH
    Chemotherapy; 1970 Mar; 15(3):177-88. PubMed ID: 5428025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.